SHARES NEWS & ANALYSIS
Your filtered view of the latest news and analysis
Section
Companies
Vectura ready for product launches Tip Update
21 May 2013
TIP UPDATE: Vectura's prospects look solid with product launches next year, but in the meantime newsflow will be thinBTG awaits regulatory news
20 May 2013
RESULTS: Speciality pharmaceutical group BTG delivered a robust full-year performance - but there's still a wait ahead before regulatory newsflow...Hutchison China MediTech makes progress
28 March 2013
RESULTS: Hutchison China MediTech is being buoyed by growing Chinese healthcare spendingGenedrive launch to boost Epistem
27 March 2013
RESULTS: Personalised medicine and diagnostics group, Epistem, is on the verge of launching its Genedrive diagnostic test - a product with significant...News & Tips: AstraZeneca, Vodafone, Bloomsbury Publishing, PV Crystalox Solar, Next, Ted Baker, Vesuvius, Solo Oil, Aminex, Turbo Power Systems & more
21 March 2013
Equities are off colour todayFutura lacks potency
07 March 2013
RESULTS: A lot depends on Futura Medical finding new licensing partners this year, but the company holds a weak handAbcam looking sequestered
05 March 2013
RESULTS: This year looks set to be a tougher one for Abcam than 2012 after enforced cuts in US research budgetsDechra's high price defence
26 February 2013
RESULTS: Dechra's operational problems are mainly related to its acquisition strategy and should correct themselves during the yearFarmers' woes hit Genus
25 February 2013
RESULTS: Livestock farming's problems were global last year and even Genus could not avoid the ensuing ill-effectsAnimalcare sees strategy results
21 February 2013
RESULTS: Animalcare's drive to improve its animal pharma business seems to be paying off as the company reports higher sales growth and better...Week Ahead 29 October - 2 November
26 October 2012
A summary of key company announcements expected in the coming weeke-Therapeutics focuses its pipeline
22 October 2012
RESULTS: e-Therapeutics is focusing its product pipeline on cancer drugs and boasts enough cash to last until mid-2014Epistem enters new territory
16 October 2012
RESULTS: The contract research market may be under pressure but Epistem is finding other ways of selling its diagnostic technologyNews & Tips: Vectura, Electrocomponents, Amerisur, Bellzone Mining, G4S, Ophir, Tanfield, Software Radio Technology & more
28 September 2012
Equities are showing signs of bouncing backAlliance Pharma heads for Europe Tip Update
12 September 2012
RESULTS: Sales pressure in its home markets has forced Alliance Pharma to look to Europe for potential leads on new acquisitionsNews & Tips: Burberry, Raven Russia, Crystal Amber, SuperGroup, GlenStrata, Betfair, Reneuron & more
11 September 2012
Equity markets are likely to remain in something of a holding pattern for the next day or so as investors await two key eventsGenus enjoys Asian demand for pork
04 September 2012
RESULTS: Porcine demand in Asia is breeding demand for Genus' breeding on-demand expertiseDechra goes shopping Tip Update
04 September 2012
An expensive summer of acquisitions underlines how quickly Dechra intends to diversify its revenuesNews & Tips: AstraZeneca, Serica Energy, San Leon, Cairn Energy, Quadrise, Range Resources, Red Emporer, G4S & more
28 August 2012
Markets are off a little at the beginning of a very busy results weekNews & Tips: United Drug, Logica, Shanta Gold & more
20 August 2012
August inertia combines with expectations of QE to keep traders sitting on last week's gainsHikma's post-spring calm
16 August 2012
RESULTS: The after-shocks of the Arab Spring have abated, for now, but Hikma's premium rating looks vulnerable to operational problems and any...News & Tips: Standard Chartered, FirstGroup, Balfour Beatty & more
15 August 2012
Is the ECB about to bite the bullet where Spain is concerned?News & Tips: Lonmin, Eckoh, Essar Energy, Centamin & more
14 August 2012
We're all poorer today following a steep rise in the CPI and a general house price fall.News & Tips: Mitie, Frontier Mining, Harvey Nash, Mediterranean Oil & Gas & more
13 August 2012
Weak economic data from Japan sets the week off on a bum note...Shire suffering an attention deficit
01 August 2012
RESULTS: Shire's operational results were solid enough, but the generic threat to its key portfolio of attention deficit drugs is undermining...Hutchison shrugs off China worries
31 July 2012
RESULTS: Hutchison China Meditech keeps meeting targets despite worries over ChinaAstraZeneca feels the patent heat Tip Update
26 July 2012
RESULTS: There's a decent dividend yield on offer at AstraZeneca, but it is hard to see the shares making any progress in what is proving to be a...GSK looks flat Tip Update
25 July 2012
TIP UPDATE: A generally tough economic environment, combined with austerity cuts to healthcare budgets means it is time to take profits on our successful...